Chemistry: analytical and immunological testing – Involving producing or treating antigen or hapten – Producing labeled antigens
Reexamination Certificate
1998-09-04
2001-02-20
Ceperley, Mary E. (Department: 1641)
Chemistry: analytical and immunological testing
Involving producing or treating antigen or hapten
Producing labeled antigens
C435S188000, C436S524000, C436S529000, C436S530000, C436S531000, C530S391100, C530S402000, C530S409000, C544S113000, C544S131000, C544S133000, C546S257000, C548S192000, C548S265400
Reexamination Certificate
active
06190923
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to the field of immunoassays for metal ions based on biological binding agents that selectively recognize and bind chelated forms of the metal ions.
BACKGROUND OF THE INVENTION
Molecules that contain two or more atoms capable of forming donor (i.e., coordinate) bonds to a single metal atom are termed chelating agents, or chelators, and the corresponding metal complexes are called chelates. The number of donor atoms present in a chelator is termed its denticity.
The chemical abbreviations used in this application are according to the Periodic Table.
The first anti-chelate antibody was described by Meares, et al., U.S. Pat. No. 4,722,892. Subsequent disclosures have described monoclonal antibodies raised against the cobalt (II) complex of ethylenediaminetetraacetic acid (EDTA) [Goodwin, et al.,
J. Nucl. Med
., 29:226-34 (1988)], indium (III) complexes of diethylenetriaminepentaacetic acid (DTPA) [Gillette, et al.,
J. Immunol. Methods
, 124:277-82 (1989); Le Doussal, et al.,
Cancer Res
., 50:3445-52 (1990)], iron (III) and cobalt (II) complexes of meso-tetrakis(carboxyphenyl)porphyrin [Schwabacher, et al.,
J. Am. Chem. Soc
., 111:2344-46 (1989)], N-methylmesoporphyrin IX [Cochran, et al.,
Science
, 249:781-83 (1990)], the tin (IV) complex of meso-tetrakis(4-carboxyvinylphenyl)porphyrin [Keinan, et al.,
Pure Appl. Chem
., 62:2013-19 (1990)] and the gallium (III) complex of HBED [Zöller, et al.,
J. Nucl. Med
., 33:1366-72(1992)]. Blake et al., [
J. Biol. Chem
., 271:27677-85 (1996)] disclose a monoclonal antibody, 2A8165, raised against a benzyl-EDTA complex of cadmium (II). The 2A81G5 antibody binds to the cadmium (II) complex of EDTA with good affinity, but also binds to the mercury (II) complex of EDTA with slightly higher affinity and to the EDTA chelates of indium (III) and manganese (II) with affinities only 3-fold and 5-fold lower, respectively, than that for Cd-EDTA. U.S. Pat. Nos. 5,476,939 and 5,631,172 of Johnson describe certain chelators, chelates, labelled tracers, antibodies directed to the chelates, and immunoassays using the antibodies and tracers. In particular, U.S. Pat. No. 5,476,939 discloses chelators derived from pyridyl and isoquinolyl carbinolamines. In addition to these premeditated efforts, a polyclonal humoral anti-chelate response has been documented in some cancer patients receiving intravenous infusions of a monoclonal antibody conjugated to the yttrium (III) chelate of 1,4,7,10-tetraazacyclododecance-N, N′,N″-tetraacetic acid (DOTA), a macrocyclic polyaminopolycarboxylate chelator [Kosmas, et al.,
Cancer Res
., 52:904-11 (1992)].
Chakrabarti et al., [
Anal. Biochem
., 217:70-75 (1994)] disclose the use of an indium-specific monoclonal antibody in an enzyme linked immunosorbent assay (ELISA) for indium (III). Wagner et al., W09010709, disclose monoclonal antibodies raised against mercury (II) and lead (II) complexes of the naturally occurring chelator glutathione and their use in heterogeneous immunoassays for these metal ions.
Quay, U.S. Pat. No. 4,687,659, discloses reaction of the cyclic dianhydride of diethylenetriaminepentaacetic acid (DTPA) with alkyl amines to give diethylenetriamine-N, N′, N″-triacetic acid (DTTA) diaminde derivatives used to prepare magnetic resonance image (MRI) contrast agents. Franklin et al., [
Inorg. Chem
., 33:5794 (1994)] disclose reaction of the cyclic dianhydride of DTPA with a diamine to give a cyclic diamide of DTTA. Li et al., [
Bioconjugate Chem
., 8:127-132 (1997)] disclose the step-wise reaction of the cyclic dianhydride of DTPA with various alkyl and aryl amines to give luminescent bifunctional lanthanide chelates.
Fluorescent polarization techniques are based on the principle that a fluorescent labelled compound when excited by linearly polarized light will emit fluorescence having a degree of polarization inversely related to its rate of rotation. Therefore, when a fluorescent labelled tracer-antibody complex is excited with linearly polarized light, the emitted light remains highly polarized because the fluorophore is constrained from rotating between the time light is absorbed and emitted. When a “free” tracer compound (i.e., unbound to an antibody) is excited by linearly polarized light, its rotation is much faster than the corresponding tracer-antibody conjugate and the molecules are more randomly oriented, therefore, the emitted light is depolarized. Thus, fluorescent polarization provides a quantitative means for measuring the amount of tracer-antibody conjugate produced in a competitive binding immunoassay.
The fluorescent polarization technique was first applied to antibody-antigen interaction by Dandliker et al. [
Immunochem
., 7:799-828 (1970); and
Immunol. Chem
., 10:219-227 (1973)]. Examples of commercially available fluorescence polarization instruments are: IMx® and Tdx® analyzers (from Abbott Laboratories, Abbott Park, Ill.) and analyzers from Panvera, Inc., Madison, Wis. None of these are specifically directed to the detection or quantification of metal ions.
SUMMARY OF THE INVENTION
One aspect of the invention presents novel bifunctional chelators which incorporate an aromatic moiety that contains one or more metal binding sites.
Another aspect of the invention presents chelates formed from the above chelators complexed to one or more metal ions.
Another aspect of the invention presents the above chelators and chelates covalently linked to a macromolecular carrier, the resulting conjugate being immunogenic.
Another aspect of the invention presents a method for using the above immunogenic conjugate for the production of antibodies that are specific for the particular chelate and bind to it, preferably with high affinity. Also presented are the resulting antibodies.
Another aspect of the invention presents the above chelate covalently linked to a detectable label (hereinafter referred to as “label”), such as a fluorophore, to produce a detectable tracer molecule, such as a fluorescent tracer molecule.
Another aspect of the invention presents the above bifunctional chelators in unconjugated form, for use in the pre-treatment of metal-containing samples to convert the metal ion present in the sample into the chelated form specifically recognized by the antibody.
Another aspect of the invention presents a method in which the above antibodies and tracers are used in an assay, preferably an immunoassay, that can detect and quantitate the metal ion of interest in the form of its chelate. Also presented are kits for conducting the above assays.
Another aspect of the invention presents methods for scavenging for metal ions in a sample and for removing metal ions from a sample.
Another aspect of the invention presents the above chelators or antibodies bound to a solid phase which are useful for the detection, quantification, scavenging, or removal of metal ions from a sample. The detection, quantification, scavenging, and removal methods are also presented.
Other aspects and advantages of the invention will be apparent to those skilled in the art upon consideration of the following detailed description which provides illustrations of the invention in its presently preferred embodiments.
REFERENCES:
patent: 4687659 (1987-08-01), Quay
patent: 4722892 (1988-02-01), Meares
patent: 5476939 (1995-12-01), Johnson
patent: 5631172 (1997-05-01), Johnson
patent: WO90/10709 (1990-09-01), None
patent: WO 95/00845 (1995-01-01), None
Blake, D. A., et al., “Metal Binding Properties of a Monoclonal Antibody Directed Toward Metal-Chelate Complexes”,J. Biol. Chem., 271(44): 27677-27685 (1996).
Brinkley, M., “A Brief Survey of Methods for Preparing Protein Conjugates with Dyes, Haptens, and Cross-Linking Reagents”,Bioconjugate Chem., 3 :2-13 (1992).
Chakrabarti, P. , et al., “Enzyme Immunoassay to Determine Heavy Metals Using Antibodies to Specific Metal-EDTA Complexes: Optimization and Validation of an Immunoassay f
Ceperley Mary E.
Wong Wean Khing
LandOfFree
Diethylenetriamine-N,N′,N″-triacetic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diethylenetriamine-N,N′,N″-triacetic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diethylenetriamine-N,N′,N″-triacetic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2594736